Loading organizations...

§ Venture Capital · San Francisco, CA, USA
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk.
Lionheart Ventures operates as a venture capital firm dedicated to the wise development of transformative technologies. It strategically invests in artificial intelligence and frontier mental health solutions, backing ethical founders building advanced technologies for significant societal impact. The firm prioritizes responsible implementation, ensuring innovations foster human flourishing and beneficial integration.
David Langer founded Lionheart Ventures as Managing Partner, drawing from his experience as a two-time technology entrepreneur. His past includes Zesty, a YC-backed catering firm acquired by Square, and co-founding GroupSpaces, a UK-based SaaS platform. Langer's insight for the firm combines his history scaling businesses with a commitment to conscious leadership and high-impact technological development.
The firm supports founders creating impactful technologies in AI and mental health, seeking both financial returns and broad societal benefits. Lionheart Ventures' vision centers on empowering humanity, ensuring responsible AI evolution, and improving mental healthcare standards. It aims for a future where technology responsibly contributes to a better, more resilient human condition.
Key people at Lionheart Ventures.
Key people at Lionheart Ventures.
Lionheart Ventures is a global, seed-stage venture capital firm with a mission to mitigate civilizational and existential risks by investing in transformative technologies. Guided by the belief that humanity’s future depends on both technological progress and collective wisdom, Lionheart focuses on sectors poised to have outsized impact: artificial intelligence and frontier mental health technologies. Their investment philosophy centers on backing ethical, high-potential founders who are building solutions that not only generate strong financial returns but also enhance human resilience, agency, and well-being. By supporting startups at the earliest stages, Lionheart plays a pivotal role in shaping the next generation of innovation in areas critical to humanity’s long-term security and flourishing.
Founded in 2019 by David Langer, a St Anne’s College, Oxford alumnus and experienced entrepreneur, Lionheart Ventures emerged from a conviction that the most pressing challenges of our time—ranging from AI-driven disruption to the global mental health crisis—require proactive, visionary investment. The firm’s leadership team includes seasoned investors and former founders, such as Brandon Goldman and Ben Lee, who bring firsthand experience in scaling startups and navigating complex technological landscapes. Over time, Lionheart has sharpened its focus, narrowing its investment thesis to AI and mental health technologies, and building a network of expert advisors in AI safety, psychedelics, and neuromodulation. This evolution reflects a deliberate strategy to maximize impact in domains where technological breakthroughs can meaningfully reduce existential risk.
Lionheart Ventures is riding the crest of two defining trends: the rapid advancement of artificial intelligence and the growing recognition of mental health as a critical determinant of societal resilience. The timing is crucial—AI is poised to reshape economies and societies, while the mental health crisis threatens collective decision-making and long-term stability. By investing in technologies that address these dual challenges, Lionheart is helping to shape a future where innovation is not only powerful but also wise and humane. Their influence extends beyond individual startups, fostering a broader ecosystem of responsible entrepreneurship and catalyzing conversations about the ethical development of transformative technologies.
Lionheart Ventures is well-positioned to continue shaping the frontier of impact-driven venture capital. As AI systems become more powerful and mental health technologies more sophisticated, the firm’s focus on ethical, high-impact innovation will only grow in relevance. Future trends—such as the integration of AI in mental health care, the rise of psychedelic medicine, and the increasing urgency of climate and existential risk mitigation—will likely amplify Lionheart’s influence. By staying true to its mission and deepening its expertise, Lionheart is not just investing in startups; it is investing in a more resilient, wiser, and more secure future for humanity.
Lionheart Ventures has more than 26 tracked investments across 24 companies. The latest tracked deal is $500K Seed in Autumn in September 2025.